LAVRX
Price
$15.88
Change
+$0.16 (+1.02%)
Updated
Jul 25 closing price
Net Assets
2.04B
VVIAX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

LAVRX vs VVIAX

Header iconLAVRX vs VVIAX Comparison
Open Charts LAVRX vs VVIAXBanner chart's image
Lord Abbett Fundamental Equity R3
Price$15.88
Change+$0.16 (+1.02%)
VolumeN/A
Net Assets2.04B
Vanguard Value Index Adm
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
LAVRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVRX vs. VVIAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 195B vs. LAVRX (2.04B). VVIAX pays higher dividends than LAVRX: VVIAX (2.18) vs LAVRX (0.58). LAVRX was incepted earlier than VVIAX: LAVRX (18 years) vs VVIAX (25 years). LAVRX (1.20) is less costly to investors than VVIAX (0.05). LAVRX is a more actively managed with annual turnover of: 39.00 vs. VVIAX (9.00). LAVRX has a lower initial minimum investment than VVIAX: LAVRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 9.75 vs. LAVRX (8.58). VVIAX return over 5 years is better than : 74.87 vs. LAVRX (56.39).
LAVRXVVIAXLAVRX / VVIAX
Total Expense Ratio1.200.052,400%
Annual Report Gross Expense Ratio1.200.052,400%
Fund Existence18 years25 years-
Gain YTD8.1746.714122%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B195B1%
Annual Yield % from dividends0.582.1826%
Returns for 1 year8.589.7588%
Returns for 3 years37.3934.32109%
Returns for 5 years56.3974.8775%
Returns for 10 years26.11116.2622%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX34.260.36
+1.06%
Fidelity Advisor Consumer Discret C
LFGTX40.810.33
+0.82%
Lord Abbett Focused Growth R5
HQIFX21.320.04
+0.19%
Hartford Equity Income F
PHPSX19.970.01
+0.05%
ProFunds Pharmaceuticals UltraSector Svc
PKAIX14.16-0.03
-0.21%
PIMCO RAE US Instl